AAV vector integration sites in mouse hepatocellular carcinoma.
about
Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancerAdeno-associated virus vector integrationA transposon and transposase system for human applicationGene therapy for mucopolysaccharidosisPreferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injectionKu70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cellsTargeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinomaThe gene therapy journey for hemophilia: are we there yet?A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiformeAnimal models of hemophiliaLong-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonatesComparative analysis of DNA nanoparticles and AAVs for ocular gene deliveryChanging channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitabilityA universal system to select gene-modified hepatocytes in vivoMeCP2-dependent repression of an imprinted miR-184 released by depolarizationEpstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J miceGene Therapy for Metabolic DiseasesImpact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinomaAnalysis of small nucleolar RNAs in sputum for lung cancer diagnosis.Lessons Learned from Animal Models of Inherited Bleeding Disorders.Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 SplicingTranslational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogsGroup II intron-based gene targeting reactions in eukaryotes.Long-term tracking of segmental bone healing mediated by genetically engineered adipose-derived stem cells: focuses on bone remodeling and potential side effects.Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.Gene expression in lung and liver after intravenous infusion of polyethylenimine complexes of Sleeping Beauty transposons.Development of a hybrid baculoviral vector for sustained transgene expressionBaculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation.Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin.AAV provides an alternative for gene therapy of the peripheral sensory nervous system.Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead.AAV-mediated liver-directed gene therapy.SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancerIncorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.Delivery of molecules into cells using localized single cell electroporation on ITO micro-electrode based transparent chip.rAAV-mediated tumorigenesis: still unresolved after an AAV assaultAdeno-associated virus-mediated gene transferGene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6.Mesenchymal stem cells for the treatment of neurodegenerative disease.
P2860
Q21245710-F491824F-42CF-4042-989B-F14F30EB69F6Q24624120-B7F68301-601D-4F9E-9E3C-484568E69075Q24630047-2331F4E4-AD56-4F0F-9237-802AACC74FBBQ24631135-2AFDBE19-D0DA-4F34-AB84-9887D9BC3BD2Q24646028-BAADD378-B0C0-49B3-A8D8-AE5FE104E736Q24650886-0E7E911E-CA88-4247-B1AA-3F056DE1E38DQ26772315-6F481FB2-78AD-4F13-90B3-A4990BD8F89FQ26823818-A67A7529-C7FD-40F6-BA8D-0A1C0CE37099Q26849375-9D948F29-0072-4609-A477-5FC0868C3E2EQ27012571-D45E2453-6F0A-418C-A7EA-0F2793A06AF0Q27318381-250D18BB-06C1-49C1-A494-B9C96C5DB92CQ27325842-E0F6E668-B179-4C97-9DDE-0EA5B6D3494AQ28081164-0D7795FC-CB8D-4746-9951-1ECE9EB1608EQ28468539-34C75484-31D7-400B-B5B0-813501C54C85Q28586909-A7FBE0CD-B2E5-4A68-9932-3D03876E3E73Q28594944-B46B2A6D-E763-489F-8D3C-ADCA4FB756EAQ28595868-E341D2F8-3DF0-41A2-8B0E-E81095A34A6CQ28750796-BDD711F1-2712-412A-A7C2-F04CC6EF1130Q30383414-4D72AEAA-94E3-464A-B7E7-F87A1646B189Q30409863-E547C771-338C-4973-B58D-E1BB806A5ABBQ30828907-217372AE-D8A5-4AF8-8966-E67D805DD87BQ30891500-A3973D3C-ABBF-49D4-8690-035FE77BF462Q33366500-BC4B0548-4126-442F-AF4C-1226A8352B07Q33571686-6A53A4E0-4F59-42D1-B2FC-0CB61A9CC966Q33684461-F9711335-48C8-4C48-B1B0-DEB174F1F4D6Q33691825-2CD19C2B-3708-4C91-A548-6F69607AAA99Q33713396-43FA5971-25F2-40D5-A729-4341E16CD910Q33713464-1286E929-5F39-4D7E-ABA0-90E037DE0909Q33732512-62CBDE9D-1549-4753-84DC-AF12119231D9Q33822179-8C894318-EAEE-4518-9F5B-1F6DC2EE9737Q33881920-54D56FA0-E2CC-4521-B6B5-AC561D3C9C47Q33930103-D8AC250D-5D8A-47D9-928D-944A1DDC0406Q33987462-92E76738-27E5-4F67-A983-B07686BF15D7Q34071777-B0A254BA-338B-440C-AFB7-F967E42625C0Q34146278-78711BBB-9449-42E0-B8CC-A9987DCD8893Q34295090-9DB0F019-F9BE-44AB-8FF1-A86B236F5007Q34310293-8B73505A-7F47-4C19-8214-7155B0E4C2D9Q34317131-F672A750-5FAD-4F46-890F-5EC12CB401AFQ34473295-95CFF606-7A6E-4BD3-93BA-4BF32E4BA311Q34473474-CC7F52B3-086E-4A65-80C7-2927776823BF
P2860
AAV vector integration sites in mouse hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
AAV vector integration sites in mouse hepatocellular carcinoma.
@en
AAV vector integration sites in mouse hepatocellular carcinoma.
@nl
type
label
AAV vector integration sites in mouse hepatocellular carcinoma.
@en
AAV vector integration sites in mouse hepatocellular carcinoma.
@nl
prefLabel
AAV vector integration sites in mouse hepatocellular carcinoma.
@en
AAV vector integration sites in mouse hepatocellular carcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
AAV vector integration sites in mouse hepatocellular carcinoma
@en
P2093
Carole Vogler
Elizabeth M Brunt
P2860
P356
10.1126/SCIENCE.1142658
P407
P577
2007-07-01T00:00:00Z